The ICREA Research Professor at IDIBELL recently demonstrated how to “hack” the immune system to slow down aging.
M. Carolina Florian: pioneering stem-cell researcher featured in Nature Read More »
Al final del recorrido, tendrá lugar un concierto en la misma playa con la actuación del grupo Dorigen, Judit Neddermann y otros invitados sorpresa.
Two weeks until Only Step, the first solidarity walk in favor of brain cancer research Read More »
Dr. Núria Lloberas, IDIBELL researcher, pharmacologist at the Nephrology Service of the Bellvitge University Hospital and associate professor at the UB, yesterday received the award for the best transplant research of 2023 awarded by the Catalan Transplant Foundation.
Thanks to the grant, the researcher from IDIBELL and the Bellvitge University Hospital will be able to carry out a research stay at the London’s Royal Brompton Hospital.
The BootStRaP project, lead by Dr Jose Manuel Menchón (IDIBELL-HUB) and Dr Naomi Fineberg (UK), aims to address the risks of problematic internet use by young people.
The first change that has been implemented is raising the temperature of the ultra-freezers to -70ºC to save energy and extend their useful life
The Green Team is born with the aim of reducing IDIBELL’s environmental impact Read More »
The Sant Joan Despí association organized an event yesterday in which Dr. Catalina Falo from IDIBELL and ICO presented the project to which the funds will be allocated and where the official delivery of the donation took place.
DACMA Association donates 12,000 euros for breast cancer research Read More »
A study with the participation of the Stroke Unit of the Bellvitge University Hospital and the IDIBELL Neurological Diseases and Neurogenetics group published in the scientific journal The New England Journal of Medicine shows that even stroke patients with extensive areas of brain damage can benefit of being treated with mechanical thrombectomy.
A study led by IDIBELL and the Bellvitge University Hospital allows progress in the personalization of treatment with the immunosuppressant Tacrolimus. The goal of researchers is to be able to limit the time that transplant patients are under- or over-exposed to the drug to minimize the risks of organ rejection and treatment toxicity.
For a year, it will analyze whether patients followed through a mobile application have a better evolution than those treated only in person.
A new study will assess teleassistance for asthma patients Read More »
